Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein
Xiaofeng Li(Wuhan Union Hospital), Thomas R. Fuerst(University of Maryland, Baltimore)
Cited by 3
Related Papers
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies
|Biotechnology Advances|2023|50
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity
|npj Vaccines|2025|7
Validation and the Determination of Antibody Bioactivity Using MILKSHAKE and Sundae Protocols
|Methods in molecular biology|2023|5